Vbi Vaccines Stock Buy Hold or Sell Recommendation
VBIVQ Stock | 0.0005 0.0001 16.67% |
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding VBI Vaccines is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell VBI Vaccines within the specified time frame.
Check out VBI Vaccines Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in VBI Stock, please use our How to Invest in VBI Vaccines guide. Note, we conduct extensive research on individual companies such as VBI and provide practical buy, sell, or hold advice based on investors' constraints. VBI Vaccines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
VBI |
Execute VBI Vaccines Buy or Sell Advice
The VBI recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on VBI Vaccines. Macroaxis does not own or have any residual interests in VBI Vaccines or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute VBI Vaccines' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Buy
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
VBI Vaccines Trading Alerts and Improvement Suggestions
VBI Vaccines generated a negative expected return over the last 90 days | |
VBI Vaccines has high historical volatility and very poor performance | |
VBI Vaccines has some characteristics of a very speculative penny stock | |
VBI Vaccines has a very high chance of going through financial distress in the upcoming years | |
The company reported the revenue of 8.68 M. Net Loss for the year was (92.84 M) with profit before overhead, payroll, taxes, and interest of 0. | |
VBI Vaccines generates negative cash flow from operations | |
VBI Vaccines has a frail financial position based on the latest SEC disclosures | |
Latest headline from finance.yahoo.com: VBI Vaccines Provides an Update on its Restructuring Proceedings and Announces Partial Revocation Order from the British Columbia Securities Commission |
VBI Vaccines Returns Distribution Density
The distribution of VBI Vaccines' historical returns is an attempt to chart the uncertainty of VBI Vaccines' future price movements. The chart of the probability distribution of VBI Vaccines daily returns describes the distribution of returns around its average expected value. We use VBI Vaccines price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of VBI Vaccines returns is essential to provide solid investment advice for VBI Vaccines.
Mean Return | -1.69 | Value At Risk | -50 | Potential Upside | 60.00 | Standard Deviation | 29.43 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of VBI Vaccines historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
VBI Vaccines Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to VBI Vaccines or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that VBI Vaccines' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a VBI stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.71 | |
β | Beta against Dow Jones | 0.36 | |
σ | Overall volatility | 29.85 | |
Ir | Information ratio | -0.06 |
VBI Vaccines Volatility Alert
VBI Vaccines is displaying above-average volatility over the selected time horizon. VBI Vaccines appears to be a penny stock. Although VBI Vaccines may be, in fact, a solid short-term or long term investment, many penny stocks are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in VBI Vaccines or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on VBI instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.VBI Vaccines Fundamentals Vs Peers
Comparing VBI Vaccines' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze VBI Vaccines' direct or indirect competition across all of the common fundamentals between VBI Vaccines and the related equities. This way, we can detect undervalued stocks with similar characteristics as VBI Vaccines or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of VBI Vaccines' fundamental indicators could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare VBI Vaccines to competition |
Fundamentals | VBI Vaccines | Peer Average |
Revenue | 8.68 M | 9.43 B |
Net Income | (92.84 M) | 570.98 M |
Total Debt | 50.77 M | 5.32 B |
Cash Flow From Operations | (60.88 M) | 971.22 M |
Number Of Employees | 131 | 18.84 K |
Total Asset | 86.95 M | 29.47 B |
Retained Earnings | (582.45 M) | 9.33 B |
Working Capital | (39.51 M) | 1.48 B |
Net Asset | 86.95 M |
VBI Vaccines Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as VBI . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 0.17 | |||
Daily Balance Of Power | (1.00) | |||
Rate Of Daily Change | 0.83 | |||
Day Median Price | 6.0E-4 | |||
Day Typical Price | 5.0E-4 | |||
Market Facilitation Index | 1.0E-4 | |||
Price Action Indicator | (0.0001) | |||
Period Momentum Indicator | (0.0001) | |||
Relative Strength Index | 28.74 |
About VBI Vaccines Buy or Sell Advice
When is the right time to buy or sell VBI Vaccines? Buying financial instruments such as VBI Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having VBI Vaccines in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Growth Thematic Idea Now
Tech Growth
Instruments that are typically traded at high earnings multiples compared to their competitors and other sectors and have been known to drive market cycles frequently. The Tech Growth theme has 66 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Growth Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.